Thrid-generation quinoloneInjectable Solution
Enrofloxacin 100 mg, excipients q.s.ad. 1 mL
For the treatment of infectious diseases caused by Gram positive and Gram negative bacteria; and mycoplasmas sensitive to enrofloxacin, mainly of the respiratory, genito-urinary and digestive tract, ear canal and skin. Bovine respiratory disease, colibacillosis, salmonellosis, pneumonia, bronchopneumonia, mycoplasmosis, dermatitis, mastitis-metritis-agalactia, rhinitis, among others.
SENASA Registry: SENASA Perú: F.69.01.N.0009